10 Feb 2026 | 3 Mins Read
Marksans Pharma reports 10.64% year-over-year sales growth
Flipitmoney
Marksans Pharma reported a 10.64% increase in net sales to Rs. 754.43 crore in December 2025 and an 8.26% rise in quarterly net profit to Rs. 113.20 crore. EBITDA increased by 8.56% to Rs. 180.89 crore. EPS rose to Rs. 2.50 in December 2025 from Rs. 2.31 in December 2024. Shares closed at 186.60 on February 06, 2026.